Abstract
The p53 tumor suppressor gene is one of the most frequently mutated genes in human cancers.* p53 is a sequence-specific transcription factor and plays a critical role in activating the expression of genes involved in cell cycle arrest or apoptosis under conditions of genotoxic stress., For over two decades, p53 was thought to be the only gene of its kind in the vertebrate genomes. This strong conviction, which was widely accepted in the p53 field, has now been proven to be incorrect. Two genes, referred to as p63 and p73, have been found to encode proteins that share a significant amino-acid identity in the transactivation domain, the DNA binding domain, and the oligomerization domain with p53. In the short period since their cloning, a number of investigators have reported on the structure, the function and the regulation of p63 and p73. This review summarizes the current information on the p63 and the p73 genes, with a focus on the differences between the three members in this newly defined p53-gene family.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by R Knight
Rights and permissions
About this article
Cite this article
Levrero, M., De Laurenzi, V., Costanzo, A. et al. Structure, function and regulation of p63 and p73. Cell Death Differ 6, 1146–1153 (1999). https://doi.org/10.1038/sj.cdd.4400624
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400624
Keywords
This article is cited by
-
Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivation
Cell Death & Differentiation (2023)
-
p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
Cell Death & Differentiation (2022)
-
Cancer predictive studies
Biology Direct (2020)
-
Commensal microbes and p53 in cancer progression
Biology Direct (2020)
-
Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death
Oncogenesis (2016)